Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

All categories
DBCAT005734Pharmacologic classL01EB

A DrugBank category of 12 drugs. 8 of them are approved.

ATC classification
Drugs

What you can answer from here — as of August 31, 2022

12DrugsEach linked to its full drug card
Listed above
8Drug targetsEvery drug–target pair in the class, with bond type
Sign in
401Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In